Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed CFO
Quarterly results
GENELABS TECHNOLOGIES INC (GNLB) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/26/2010 SC 13G/A Merlin BioMed Private Equity Advisors, L.L.C. reports a 0% stake in Genelabs Technologies Inc.
02/17/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2009 SC 13G GALLEON MANAGEMENT L P reports a 0% stake in Genelabs Technologies, Inc.
02/10/2009 SC 13G/A MORGAN STANLEY reports a 0% stake in GENELABS TECHNOLOGIES INC
02/10/2009 SC 13G/A MORGAN STANLEY reports a 12.3% stake in GENELABS TECHNOLOGIES INC
01/30/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
01/20/2009 15-12G Form 15-12G -- Securities registration termination [Section 12(g)]
01/20/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-01-16 Registration Form: POS AM Reference AccNo: 0000950123-09-000794
01/16/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/16/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/16/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/16/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
01/09/2009 8-K Quarterly results
01/07/2009 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
12/30/2008 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
12/15/2008 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
12/05/2008 SC 13G/A GENELABS TECHNOLOGIES INC /CA reports a 4.1% stake in Genelabs Technologies, Inc.
11/13/2008 10-Q Quarterly Report for the period ended September 30, 2008
11/13/2008 8-K Quarterly results
Docs: "GENELABS REPORTS RESULTS FOR THE THIRD QUARTER"
11/05/2008 10-Q/A Quarterly Report for the period ended March 31, 2008 [amend]
11/05/2008 10-K/A Annual Report for the period ended December 31, 2007 [amend]
11/03/2008 8-K Form 8-K -- Current report
10/30/2008 8-K/A Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Consulting Agreement, effective as of October 3, 2008, by and between Kenneth E. Schwartz, M.D. and Genelabs Technologies, Inc"
10/07/2008 8-K Form 8-K -- Current report
09/04/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Offer Letter Entered into between Genelabs Technologies, Inc. and Frederick W. Driscoll",
"Genelabs Technologies, Inc. Announces Appointment of Frederick W. Driscoll as President and CEO"
08/12/2008 10-Q Quarterly Report for the period ended June 30, 2008
08/12/2008 8-K Quarterly results
Docs: "GENELABS REPORTS RESULTS FOR THE SECOND QUARTER AND FIRST SIX MONTHS OF 2008"
07/10/2008 8-K Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from Ernst & Young LLP"
06/23/2008 8-K Termination of a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Genelabs Provides Update on Hepatitis C Drug Development With Collaboration Partners"
05/14/2008 8-K Quarterly results
Docs: "GENELABS REPORTS RESULTS FOR THE FIRST QUARTER OF 2008 AND"
05/13/2008 10-Q Quarterly Report for the period ended March 31, 2008
04/25/2008 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/25/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
03/28/2008 10-K Annual Report for the period ended December 31, 2007
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy